Lexicon Pharmaceuticals Inc.
LXRX | NASDAQ
$2.12
+$0.08 (+3.92%)
Sep 22, 2026, 1:03 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -62.16M | -26.09M | -50.34M | -68.58M | -120.62M | -177.3M | -200.4M | -216.39M | -202.11M | -193.58M | -177.12M | -157.86M | -130.72M | -110.4M | -101.94M | -97.06M | -96.8M | -90.28M | -87.76M | -67.64M | 38.08M | -12.92M |
Depreciation & Amortization | 591K | 555K | 621K | 628K | 603K | 566K | 534K | 556K | 581K | 586K | 554K | 510K | 467K | 430K | 427K | 436K | 429K | 364K | 292K | 524K | 1.21M | 2.07M |
Stock-Based Compensation | 15.77M | 12.55M | 12.52M | 11.22M | 10.58M | 12.24M | 13.5M | 15.17M | 16.27M | 15.23M | 14.34M | 14.4M | 13.15M | 12.16M | 11.52M | 10.48M | 10.54M | 10.5M | 10.58M | 11.03M | 10.22M | 11.69M |
Other Working Capital | 1.25M | 766K | 2.29M | 3.83M | 5.14M | 4.86M | 1.75M | -1.95M | -1.56M | -3.68M | -2.43M | -1.07M | -2.43M | -607K | 340K | 961K | 2.52M | 3.01M | 3.55M | 2.55M | -938K | -1.79M |
Other Non-Cash Items | 6.7M | 1.69M | -309K | -1.36M | -5.88M | -9.4M | -6.65M | -5.37M | -6.94M | -2.31M | -2.33M | -2.11M | 1.1M | 984K | 744K | 453K | 253K | 114K | 103K | -132.52M | -132.27M | -130.32M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 130.85M | -1.71M | -1.71M |
Change in Working Capital | -37.17M | -24.07M | -26.89M | -10.58M | 13.42M | 6.47M | 14.24M | -1.81M | -3.65M | -5.34M | 2.66M | 12.14M | 5.27M | -218K | 402K | -4.42M | -2.25M | -5.98M | -10.23M | -40.67M | -37.19M | -14.88M |
Operating Cash Flow | -79.72M | -38.8M | -67.85M | -72.11M | -101.9M | -167.43M | -178.78M | -207.84M | -195.84M | -185.41M | -161.9M | -132.92M | -110.74M | -97.04M | -88.85M | -90.11M | -87.82M | -85.28M | -87.02M | -98.43M | -121.66M | -146.07M |
Capital Expenditures | n/a | n/a | n/a | -474K | -781K | -1.03M | -1.03M | -557K | -333K | -222K | -470K | -1.72M | -1.64M | -1.5M | -1.33M | -103K | -312K | -1.26M | -1.22M | -1.25M | -1.07M | -125K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.24M | 39.24M | 39.24M | 13.82M | -25.42M | -25.42M | -25.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -318.52M | -182.48M | -141.49M | -144.71M | -160.61M | -210.49M | -328.75M | -303.02M | -332.64M | -377.7M | -223.34M | -223.83M | -244.78M | -145M | -133.95M | -138.74M | -50.06M | -30.39M | -34.26M | -34.24M | -45.78M | -47.02M |
Sales Maturities Of Investments | 218.04M | 183M | 252.86M | 305.86M | 323.41M | 346.95M | 314.4M | 286.4M | 223M | 205.67M | 173.87M | 147.88M | 130.88M | 91.92M | 64.2M | 49.69M | 38.01M | 47.08M | 37.59M | 64.59M | 131.77M | 196M |
Other Investing Acitivies | 440K | 1.65M | 1.65M | 1.21M | 1.21M | n/a | n/a | n/a | -39.24M | -39.24M | -39.24M | -13.82M | 25.42M | 25.42M | 25.42M | n/a | n/a | n/a | n/a | 11.01M | 171.4M | 171.4M |
Investing Cash Flow | -100.03M | 2.18M | 113.02M | 161.89M | 163.23M | 135.43M | -15.38M | -17.18M | -109.98M | -172.26M | -49.94M | -77.67M | -115.54M | -54.58M | -71.08M | -89.16M | -12.36M | 15.43M | 2.11M | 40.12M | 256.32M | 320.25M |
Debt Repayment | -12.26M | -53M | -48M | -45M | -45M | n/a | n/a | -1K | n/a | 49.96M | 49.96M | 74.93M | 74.68M | 24.72M | 48.87M | 12.2M | 12.45M | 12.45M | -11.7M | -5.82M | -215.94M | -216.26M |
Common Stock Repurchased | n/a | n/a | -572K | -572K | -572K | -572K | n/a | n/a | n/a | n/a | -824K | -824K | -824K | -824K | -864K | -864K | -864K | -864K | -2.68M | -2.68M | -2.68M | -2.78M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -7.96M | -2.84M | n/a | 63K | -843K | -843K | -2.97M | -3.04M | -2.13M | -2.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 174.07M | 40.83M | -48.5M | -45.68M | -46.59M | -1.61M | 238.35M | 238.45M | 239.16M | 428.17M | 187.96M | 212.87M | 307.1M | 118.1M | 142.21M | 105.98M | 31.74M | 31.72M | 22.71M | 98.18M | -131.72M | -132.12M |
Net Cash Flow | -5.68M | 4.2M | -3.33M | 44.11M | 14.75M | -33.61M | 44.19M | 13.44M | -66.65M | 70.49M | -23.88M | 2.28M | 80.82M | -33.52M | -17.72M | -73.28M | -68.44M | -38.13M | -62.2M | 39.87M | 2.94M | 42.06M |
Free Cash Flow | -79.72M | -38.8M | -67.85M | -72.58M | -102.68M | -168.46M | -179.81M | -208.39M | -196.17M | -185.64M | -162.37M | -134.63M | -112.38M | -98.54M | -90.18M | -90.21M | -88.13M | -86.54M | -88.24M | -99.68M | -122.73M | -146.2M |
Adj. Free Cash Flow | -95.49M | -51.36M | -80.37M | -83.8M | -113.25M | -180.7M | -193.31M | -223.57M | -212.44M | -200.86M | -176.71M | -149.03M | -125.52M | -110.7M | -101.7M | -100.69M | -98.68M | -97.04M | -98.82M | -110.71M | -132.95M | -157.89M |
Maintenance CapEx | n/a | n/a | n/a | n/a | -102.37K | -180.99K | -180.99K | -180.99K | -145.1K | -167.6K | -415.6K | -1.66M | -1.6M | -1.49M | -1.32M | -99.47K | -310.64K | -1.26M | -1.22M | -1.25M | -1.07M | -125K |
Growth CapEx | n/a | n/a | n/a | -474K | -678.63K | -850.01K | -850.01K | -376.01K | -187.91K | -54.4K | -54.4K | -56.3K | -41.95K | -4.07K | -5.43K | -3.53K | -1.36K | -1.36K | n/a | n/a | n/a | n/a |
Owner Earnings | -79.72M | -38.8M | -67.85M | -72.11M | -102M | -167.61M | -178.96M | -208.02M | -195.98M | -185.58M | -162.31M | -134.58M | -112.33M | -98.54M | -90.17M | -90.21M | -88.13M | -86.54M | -88.24M | -99.68M | -122.73M | -146.2M |
Add to Watchlist
Select watchlists to add or remove LXRX